Core Laboratories (NYSE:CLB) Upgraded by Wall Street Zen to “Hold” Rating

Core Laboratories (NYSE:CLB) was upgraded by stock analysts at Wall Street Zen from a “sell” rating to a “hold” rating in a research report issued on Saturday.

Separately, Weiss Ratings cut Core Laboratories from a “hold (c)” rating to a “hold (c-)” rating in a research report on Monday, May 4th. Three research analysts have rated the stock with a Hold rating, According to MarketBeat.com, Core Laboratories currently has an average rating of “Hold” and a consensus target price of $12.00.

Core Laboratories Stock Down 0.1%

NYSE:CLB opened at $11.68 on Friday. The firm has a market cap of $538.49 million, a P/E ratio of 17.97, a P/E/G ratio of 2.26 and a beta of 0.98. The company has a debt-to-equity ratio of 0.42, a quick ratio of 1.50 and a current ratio of 2.05. Core Laboratories has a fifty-two week low of $9.72 and a fifty-two week high of $20.36. The firm has a 50-day simple moving average of $14.43 and a two-hundred day simple moving average of $16.39.

Core Laboratories (NYSE:CLB) last issued its earnings results on Wednesday, April 29th. The oil and gas company reported $0.06 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.06. Core Laboratories had a net margin of 5.94% and a return on equity of 11.52%. The firm had revenue of $121.80 million for the quarter, compared to the consensus estimate of $122.99 million. During the same quarter in the prior year, the firm posted $0.14 earnings per share. The business’s revenue was down 1.4% on a year-over-year basis. Core Laboratories has set its Q2 2026 guidance at 0.060-0.120 EPS. Analysts predict that Core Laboratories will post 0.56 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Core Laboratories

Hedge funds and other institutional investors have recently modified their holdings of the company. CWM LLC grew its holdings in shares of Core Laboratories by 36.1% in the fourth quarter. CWM LLC now owns 2,516 shares of the oil and gas company’s stock worth $40,000 after acquiring an additional 668 shares during the period. Platinum Investment Management Ltd. increased its position in Core Laboratories by 3.9% during the third quarter. Platinum Investment Management Ltd. now owns 23,758 shares of the oil and gas company’s stock valued at $294,000 after acquiring an additional 889 shares during the last quarter. Illinois Municipal Retirement Fund lifted its holdings in Core Laboratories by 4.0% in the third quarter. Illinois Municipal Retirement Fund now owns 23,366 shares of the oil and gas company’s stock valued at $289,000 after acquiring an additional 898 shares during the period. Fox Run Management L.L.C. lifted its holdings in Core Laboratories by 5.9% in the third quarter. Fox Run Management L.L.C. now owns 18,531 shares of the oil and gas company’s stock valued at $229,000 after acquiring an additional 1,038 shares during the period. Finally, The Manufacturers Life Insurance Company boosted its position in Core Laboratories by 6.2% in the second quarter. The Manufacturers Life Insurance Company now owns 17,932 shares of the oil and gas company’s stock worth $207,000 after purchasing an additional 1,040 shares during the last quarter. 97.81% of the stock is owned by institutional investors.

About Core Laboratories

Core Laboratories N.V. is a global provider of proprietary and patented reservoir description and production enhancement services to the oil and gas industry. The company applies specialized expertise in core and fluid analysis, advanced petrophysical interpretation, and reservoir engineering to optimize hydrocarbon recovery. By integrating laboratory testing with field services and digital analytics, Core Laboratories delivers insights that help operators maximize production and extend the life of their assets.

The company’s portfolio spans two primary service lines: reservoir description and production enhancement.